Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
May-2026 Volume 68 Issue 5

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2026 Volume 68 Issue 5

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization

  • Authors:
    • Qian Li
    • Minghua Jiang
    • Biqing Zhu
    • Wei Wei
    • Lei Xia
    • Jian Huang
    • Han Gao
    • Mingyu Du
  • View Affiliations / Copyright

    Affiliations: Department of Radiation Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China, Department of General Surgery, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China, Department of Pathology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 62
    |
    Published online on: March 20, 2026
       https://doi.org/10.3892/ijo.2026.5875
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Radiotherapy remains an irreplaceable treatment modality for breast cancer (BC). Calmodulin‑binding Transcription Activator 1 (CAMTA1) has been implicated in tumor progression; however, its role in BC is unclear. The present study aimed to elucidate the mechanistic function of CAMTA1 in BC. RNA sequencing was performed on RAW264.7 macrophages co‑cultured with 4T1 cells and subjected to X‑ray irradiation. In vitro, THP‑1 cells were co‑cultured with MDA‑MB‑231 cells under hypoxic conditions. Exosome morphology was observed under transmission electron microscopy and PKH67 staining was used to trace exosome uptake. Flow cytometry was used to detect CD163 expression while ELISA measured the levels of IL‑10 and IL‑12. Reverse transcription‑quantitative (RT‑q) PCR and immunoblotting analysis were used to detect the expressions of neuregulin 1 (NRG1), CAMTA1 and hypoxia‑inducible factor‑1α. Cell apoptosis, cell cycle distribution, cell viability and proliferation were evaluated using flow cytometry, MTT assay and colony formation assay. In vivo, transfected MDA‑MB‑231 cells were injected into BALB/c nude mice combined with radiotherapy and exosome injection. Histopathological changes in tumor tissues were examined using H&E staining. Immunohistochemistry analysis was performed to assess the expressions of NRG1, Caspase‑3 and CD163. RNA sequencing, RT‑qPCR and immunoblotting analysis revealed that NRG1 expression was markedly increased in RAW264.7 macrophages co‑cultured with 4T1 cells. NRG1 was found to be involved in M2 polarization induced by hypoxia‑treated MDA‑MB‑231 cells, which in turn promoted radio‑resistance. CAMTA1 expression was highly expressed in exosomes derived from hypoxic MDA‑MB‑231 cells and exosomal CAMTA1 promoted the M2 polarization of THP‑1 macrophages. In vivo, CAMTA1 overexpression greatly enhanced tumor growth, increased NRG1 expression, inhibited cell apoptosis and promoted M2 polarization of macrophages in tumor tissue. MDA‑MB‑231 cells were found to deliver CAMTA1 to macrophages via exosomes, leading to upregulation of NRG1 and induction of M2 polarization, thereby enhancing BC cells resistance to radiotherapy. These findings provided novel insights into the mechanisms underlying radio‑resistance in BC and identify exosomal CAMTA1 as a potential therapeutic target.
View Figures

Figure 1

NRG1 expression is elevated in
RAW264.7 macrophages co-cultured with 4T1 cells. (A) The expression
of NRG1 was examined using next-generation RNA sequencing analysis.
(B) The mRNA expression of NRG1 in RAW264.7 macrophages co-cultured
with 4T1 cells was detected using reverse
transcription-quantitative PCR. (C) The protein expression of NRG1
in RAW264.7 macrophages co-cultured with 4T1 cells was detected
using immunoblotting analysis. ***P<0.001. NRG1,
neuregulin 1.

Figure 2

Hypoxic MDA-MB-231 cells induces the
M2 polarization of THP-1 macrophages. (A) The protein expression of
HIF-1α was assessed using immunoblotting analysis. (B) The protein
expression of HIF-1α in hypoxic MDA-MB-231/THP-1 co-cultures was
assessed using immunoblotting analysis. (C) The cell migration was
detected using Transwell. (D and E) The level of CD163 was detected
using flow cytometry. The levels of (F) IL-10 and (G) IL-12 were
detected using ELISA-related assay kits. **P<0.01 and
***P<0.001. HIF-1α, hypoxia-inducible factor-1α.

Figure 3

M2 polarization enhances the
resistance of MDA-MB-231 cells to radiotherapy. (A) The cell
viability was detected using MTT assay. (B and C) The cell
apoptosis was detected using flow cytometry. (D and E) The cell
cycle was detected using flow cytometry. (F and G) Cell
proliferation was detected using colony formation assay.
*P<0.05, **P<0.01 and
***P<0.001.

Figure 4

NRG1 expression is associated with M2
polarization and poor prognosis. (A) The expression of NRG1 in BC
samples using TCGA database. (B) Spearman correlation analysis
between NRG1 and CD163 expression in breast cancer samples. (C) The
association of NRG1 expression with the overall survival in BC
patients. NRG1, neuregulin 1; BC, breast cancer; TCGA, The Cancer
Genome Atlas; GEPIA, Gene Expression Profiling Interactive
Analysis.

Figure 5

Hypoxic MDA-MB-231 cells induces the
M2 polarization of THP-1 macrophages via NRG1. (A) The mRNA
expression of NRG1 was detected using RT-qPCR. (B) The transfection
efficacy of Ov-NRG1 was detected using RT-qPCR and immunoblotting
analysis. (C) The transfection efficacy of si-NRG1 was detected
using RT-qPCR and immunoblotting analysis. (D) The level of IL-10
was detected using ELISA-related IL-10 assay kits. (E and F) The
level of CD163 was detected using flow cytometry. (G) Following the
treatment of anti-NRG1 blocking antibody, the level of IL-10 was
detected using ELISA-related IL-10 assay kits. (H-I) Following the
treatment of anti-NRG1 blocking antibody, the level of CD163 was
detected using flow cytometry. *P<0.05,
**P<0.01 and ***P<0.001. NRG1,
neuregulin 1; RT-qPCR, reverse transcription-quantitative PCR; Ov,
overexpression; si, small interfering.

Figure 6

Hypoxic MDA-MB-231 cells mediate the
M2 polarization of THP-1 macrophages via exosomes. (A) The cell
migration was detected using Transwell. Scale: 100 μm. (B)
The level of CD163 was detected using flow cytometry analysis. (C)
The level for IL-10 was detected using ELISA-related IL-10 assay
kits. (D) Transmission electron microscope was used for the
inspection of exosomes. Scale: 100 μm. (E) The analysis of
exosome particle size. (F) The expressions of exosomal marker
proteins were detected using immunoblotting analysis. (G) PKH67
staining was used to trace the exosomes. (H) The level of CD163 was
detected using flow cytometry analysis. **P<0.01 and
***P<0.001.

Figure 7

Exosomal CAMTA1 promotes the M2
polarization of THP-1 macrophages. (A) The expression of CAMTA1 in
BC samples was predicted using TCGA database. (B) The mRNA
expression of CAMTA1 in MDA-MB-231 cells was detected using
RT-qPCR. (C) The mRNA expression of CAMTA1 in exosomes was detected
using RT-qPCR. (D) The mRNA expression of CAMTA1 in THP-1
macrophages was detected using RT-qPCR. (E) The transfection
efficacy of sh-CAMTA1 was detected using RT-qPCR and immunoblotting
analysis. (F) The mRNA expression of CAMTA1 in transfected
MDA-MB-231 cells was detected using RT-qPCR. (G) The mRNA
expression of CAMTA1 in transfected exosomes was detected using
RT-qPCR. (H) The cell migration was detected using Transwell. (I
and J) The level of CD163 was detected using flow cytometry
analysis. (K) The level of IL-10 was detected using ELISA-related
IL-10 assay kits. *P<0.05, **P<0.01 and
***P<0.001. CAMTA1, Calmodulin-binding Transcription
Activator 1; BC, breast cancer; TCGA, The Cancer Genome Atlas;
RT-qPCR, reverse transcription-quantitative PCR; sh, short
hairpin.

Figure 8

Exosomal CAMTA1 promotes tumor growth
in vivo. (A) The transfection efficacy of Ov-CAMTA1 was
detected using RT-qPCR and immunoblotting analysis. (B) The
appearance of tumor. The tumor (C) volume and (D) weight. (E) The
mRNA expression of CAMTA1 was detected using RT-qPCR. (F) The level
of IL-10 was detected using ELISA-related IL-10 assay kits. (G) The
level of CD163 was detected using immunohistochemistry analysis.
(H) H&E staining. (I) The expression of Caspase 3 was detected
using immunohistochemistry analysis. (J) The Spearman correlation
analysis of CAMTA1 and NRG1. (K) The expression of NRG1 was
detected using immunohistochemistry analysis.
*P<0.05, **P<0.01 and
***P<0.001. CAMTA1, Calmodulin-binding Transcription
Activator 1; Ov, overexpression; RT-qPCR, reverse
transcription-quantitative PCR; H&E, hematoxylin and eosin;
NRG1, neuregulin 1.
View References

1 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI

2 

Li T, Mello-Thoms C and Brennan PC: Descriptive epidemiology of breast cancer in China: Incidence, mortality, survival and prevalence. Breast Cancer Res Treat. 159:395–406. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Liyanage PY, Hettiarachchi SD, Zhou Y, Ouhtit A, Seven ES, Oztan CY, Celik E and Leblanc RM: Nanoparticle-mediated targeted drug delivery for breast cancer treatment. Biochim Biophys Acta Rev Cancer. 1871:419–433. 2019. View Article : Google Scholar : PubMed/NCBI

4 

Tan C, Hu W, He Y, Zhang Y, Zhang G, Xu Y and Tang J: Cytokine-mediated therapeutic resistance in breast cancer. Cytokine. 108:151–159. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Nalio Ramos R, Missolo-Koussou Y, Gerber-Ferder Y, Bromley CP, Bugatti M, Núñez NG, Tosello Boari J, Richer W, Menger L, Denizeau J, et al: Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer. Cell. 185:1189–1207.e25. 2022. View Article : Google Scholar

6 

Pan Y, Yu Y, Wang X and Zhang T: Tumor-associated macrophages in tumor immunity. Front Immunol. 11:5830842020. View Article : Google Scholar : PubMed/NCBI

7 

Rahal OM, Wolfe AR, Mandal PK, Larson R, Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS and Woodward WA: Blocking Interleukin (IL)4- and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 100:1034–1043. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Finkler A, Ashery-Padan R and Fromm H: CAMTAs: Calmodulin-binding transcription activators from plants to human. FEBS Lett. 581:3893–3898. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O: Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 6:63–70. 1999. View Article : Google Scholar : PubMed/NCBI

10 

Henrich KO, Claas A, Praml C, Benner A, Mollenhauer J, Poustka A, Schwab M and Westermann F: Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma. Eur J Cancer. 43:607–616. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Pan R, Zhang Z, Jia H, Ma J, Wu C, Xue P, Cai W, Zhang X and Sun J: CAMTA1-PPP3CA-NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin. Cell Death Discov. 8:1292022. View Article : Google Scholar : PubMed/NCBI

12 

Drilon A, Somwar R, Mangatt BP, Edgren H, Desmeules P, Ruusulehto A, Smith RS, Delasos L, Vojnic M, Plodkowski AJ, et al: Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers. Cancer Discov. 8:686–695. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Jonna S, Feldman RA, Swensen J, Gatalica Z, Korn WM, Borghaei H, Ma PC, Nieva JJ, Spira AI, Vanderwalde AM, et al: Detection of NRG1 gene fusions in solid tumors. Clin Cancer Res. 25:4966–6972. 2019. View Article : Google Scholar : PubMed/NCBI

14 

Yun S, Koh J, Nam SK, Park JO, Lee SM, Lee K, Lee KS, Ahn SH, Park DJ, Kim HH, et al: Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients. Gastric Cancer. 21:225–236. 2018. View Article : Google Scholar

15 

Shu L, Chen A, Li L, Yao L, He Y, Xu J, Gu W, Li Q, Wang K, Zhang T and Liu G: NRG1 regulates Fra-1 transcription and metastasis of triple-negative breast cancer cells via the c-Myc ubiquitination as manipulated by ERK1/2-mediated Fbxw7 phosphorylation. Oncogene. 41:907–919. 2022. View Article : Google Scholar : PubMed/NCBI

16 

Yi C, Wu S, Duan Q, Liu L, Li L, Luo Y and Wang A: Ferroptosis-dependent breast cancer cell-derived exosomes inhibit migration and invasion of breast cancer cells by suppressing M2 macrophage polarization. PeerJ. 11:e150602023. View Article : Google Scholar : PubMed/NCBI

17 

Liu C, Huang X, Li S, Ji W, Luo T, Liang J and Lv Y: M2 macrophage-derived exosomes reverse TGF-β1-induced epithelial mesenchymal transformation in BEAS-2B cells via the TGF-βRI/Smad2/3 signaling pathway. Eur J Med Res. 30:2712025. View Article : Google Scholar

18 

Lu F, Ye M, Shen Y, Xu Y, Hu C, Chen J, Yu P, Xue B, Gu D, Xu L, et al: Hypoxic tumor-derived exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3/FABP5 mediated fatty acid oxidation. Int J Biol Sci. 20:3201–3218. 2024. View Article : Google Scholar : PubMed/NCBI

19 

Yang Y, Li CW, Chan LC, Wei Y, Hsu JM, Xia W, Cha JH, Hou J, Hsu JL, Sun L and Hung MC: Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 28:862–864. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Hansen MR, Roehm PC, Chatterjee P and Green SH: Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation. Glia. 53:593–600. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Yang Y, Wu T, Wang Y, Luo D, Zhao Z, Sun H, Zhang M, Zhang B and Han B: Hypoxic tumour-derived exosomal miR-1290 exacerbates the suppression of CD8+ T cells by promoting M2 macrophage polarization. Immunology. 173:672–688. 2024. View Article : Google Scholar : PubMed/NCBI

22 

Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu M, Qian Y, Zhang X, Ji R, Wang S, et al: M2 Tumor-associated macrophages-derived exosomal MALAT1 promotes glycolysis and gastric cancer progression. Adv Sci (Weinh). 11:e23092982024. View Article : Google Scholar : PubMed/NCBI

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

24 

Ye M, Lu F, Gu D, Xue B, Xu L, Hu C, Chen J, Yu P, Zheng H, Gao Y, et al: Hypoxia exosome derived CEACAM5 promotes tumor-associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9. FASEB J. 38:e237622024. View Article : Google Scholar : PubMed/NCBI

25 

Guo M, Wang R, Nie M, Zhang H, Wang C, Song C and Niu S: H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer. Cell Signal. 120:1111962024. View Article : Google Scholar

26 

Jiang D, Gao X, Tan R, Liu X, Zhu Y and Zhang L: Euphorbia factor L1 suppresses breast cancer liver metastasis via DDR1-mediated immune infiltration. Aging. 15:9217–9229. 2023. View Article : Google Scholar : PubMed/NCBI

27 

Schito L and Semenza GL: Hypoxia-inducible factors: Master regulators of cancer progression. Trends Cancer. 2:758–770. 2016. View Article : Google Scholar

28 

King HW, Michael MZ and Gleadle JM: Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 12:4212012. View Article : Google Scholar :

29 

Yang Y, Jin X, Xie Y, Ning C, Ai Y, Wei H, Xu X, Ge X, Yi T, Huang Q, et al: The CEBPB+ glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growth. Theranostics. 14:4107–4126. 2024. View Article : Google Scholar

30 

Sun Y, Lian Y, Mei X, Xia J, Feng L, Gao J, Xu H, Zhang X, Yang H, Hao X and Feng Y: Cinobufagin inhibits M2-like tumor-associated macrophage polarization to attenuate the invasion and migration of lung cancer cells. Int J Oncol. 65:1022024. View Article : Google Scholar

31 

Jiang Z, Zhang Y, Zhang Y, Jia Z, Zhang Z and Yang J: Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression. Cell Commun Signal. 19:932021. View Article : Google Scholar : PubMed/NCBI

32 

Wang X, Zhou Y, Dong K, Zhang H, Gong J and Wang S: Exosomal lncRNA HMMR-AS1 mediates macrophage polarization through miR-147a/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma. Environ Toxicol. 37:1357–1372. 2022. View Article : Google Scholar : PubMed/NCBI

33 

Hao C, Sheng Z, Wang W, Feng R, Zheng Y, Xiao Q and Zhang B: Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion. Thorac Cancer. 14:1477–1491. 2023. View Article : Google Scholar : PubMed/NCBI

34 

Schraivogel D, Weinmann L, Beier D, Tabatabai G, Eichner A, Zhu JY, Anton M, Sixt M, Weller M, Beier CP and Meister G: CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J. 30:4309–4322. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Shi DM, Li LX, Bian XY, Shi XJ, Lu LL, Zhou HX, Pan TJ, Zhou J, Fan J and Wu WZ: miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling. J Exp Clin Cancer Res. 37:2942018. View Article : Google Scholar : PubMed/NCBI

36 

Zhang TT, Qu N, Sun GH, Zhang L, Wang YJ, Mu XM, Wei WJ, Wang YL, Wang Y, Ji QH, et al: NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer. Int J Oncol. 53:685–693. 2018.PubMed/NCBI

37 

Alizadeh A, Santhosh KT, Kataria H, Gounni AS and Karimi-Abdolrezaee S: Neuregulin-1 elicits a regulatory immune response following traumatic spinal cord injury. J Neuroinflammation. 15:532018. View Article : Google Scholar : PubMed/NCBI

38 

Ma Y, Fan P, Zhao R, Zhang Y, Wang X and Cui W: Neuregulin-1 regulates the conversion of M1/M2 microglia phenotype via ErbB4-dependent inhibition of the NF-κB pathway. Mol Biol Rep. 49:3975–3986. 2022. View Article : Google Scholar : PubMed/NCBI

39 

Chen X, Wan Z, Yang L, Song S, Fu Z, Tang K, Chen L and Song Y: Exosomes derived from reparative M2-like macrophages prevent bone loss in murine periodontitis models via IL-10 mRNA. J Nanobiotechnol. 20:1102022. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Q, Jiang M, Zhu B, Wei W, Xia L, Huang J, Gao H and Du M: Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization. Int J Oncol 68: 62, 2026.
APA
Li, Q., Jiang, M., Zhu, B., Wei, W., Xia, L., Huang, J. ... Du, M. (2026). Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization. International Journal of Oncology, 68, 62. https://doi.org/10.3892/ijo.2026.5875
MLA
Li, Q., Jiang, M., Zhu, B., Wei, W., Xia, L., Huang, J., Gao, H., Du, M."Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization". International Journal of Oncology 68.5 (2026): 62.
Chicago
Li, Q., Jiang, M., Zhu, B., Wei, W., Xia, L., Huang, J., Gao, H., Du, M."Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization". International Journal of Oncology 68, no. 5 (2026): 62. https://doi.org/10.3892/ijo.2026.5875
Copy and paste a formatted citation
x
Spandidos Publications style
Li Q, Jiang M, Zhu B, Wei W, Xia L, Huang J, Gao H and Du M: Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization. Int J Oncol 68: 62, 2026.
APA
Li, Q., Jiang, M., Zhu, B., Wei, W., Xia, L., Huang, J. ... Du, M. (2026). Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization. International Journal of Oncology, 68, 62. https://doi.org/10.3892/ijo.2026.5875
MLA
Li, Q., Jiang, M., Zhu, B., Wei, W., Xia, L., Huang, J., Gao, H., Du, M."Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization". International Journal of Oncology 68.5 (2026): 62.
Chicago
Li, Q., Jiang, M., Zhu, B., Wei, W., Xia, L., Huang, J., Gao, H., Du, M."Hypoxia‑induced exosomal CAMTA1 promotes radio‑resistance in MDA‑MB‑231 cells by regulating NRG1 to mediate M2 macrophage polarization". International Journal of Oncology 68, no. 5 (2026): 62. https://doi.org/10.3892/ijo.2026.5875
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team